.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Medtronic
Chinese Patent Office
US Army
Mallinckrodt
Farmers Insurance
McKinsey
Fuji
Julphar
Healthtrust

Generated: September 20, 2017

DrugPatentWatch Database Preview

PROCHLORPERAZINE EDISYLATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prochlorperazine edisylate and what is the scope of prochlorperazine edisylate patent protection?

Prochlorperazine edisylate
is the generic ingredient in three branded drugs marketed by Hospira, West-ward Pharms Int, Teva Parenteral, Watson Labs, Athenex Inc, Glaxosmithkline, Emcure Pharms Ltd, Wyeth Ayerst, Smith And Nephew, Alpharma Us Pharms, Baxter Hlthcare, Marsam Pharms Llc, and Morton Grove, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for prochlorperazine edisylate. Four suppliers are listed for this compound.

Summary for Generic Name: PROCHLORPERAZINE EDISYLATE

Tradenames:3
Patents:0
Applicants:13
NDAs:20
Drug Master File Entries: see list19
Suppliers / Packagers: see list4
Bulk Api Vendors: see list9
Clinical Trials: see list36
Patent Applications: see list425
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:PROCHLORPERAZINE EDISYLATE at DailyMed

Pharmacology for Ingredient: PROCHLORPERAZINE EDISYLATE

Ingredient-typePhenothiazines
Drug ClassPhenothiazine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Marsam Pharms Llc
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION089675-001Dec 5, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Smith And Nephew
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION089251-001Dec 4, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine edisylate
INJECTABLE;INJECTION010742-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION086348-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
SYRUP;ORAL087154-001Sep 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine edisylate
SYRUP;ORAL011188-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine edisylate
CONCENTRATE;ORAL011276-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION089606-001Jul 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION089903-001Aug 29, 1989APRXNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
PROCHLORPERAZINE
prochlorperazine edisylate
INJECTABLE;INJECTION087759-001Oct 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Medtronic
Johnson and Johnson
Novartis
Chubb
Dow
Cipla
Covington
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot